Australia's largest stock trading and investment forum Australia's #1 stock forum

RXP

Click for more information

0.00%

49.5¢ rxp services limited

I reckon you may be shooting a little high with the 2cps interim...

First 22 Last

Share
Profile

Follow
whitepointer

1,191 Posts.

122

15/02/18

08:44

Post #: 31066225
Share

Originally posted by afterlife ↑

So, here we are few days before the HY report, SP has shed off few more cents of late, and I have been adding more shares to my already large Holdings of RXP in my portfolio.

Regardless of a possible bias and blind compulsion on my behalf, this is what i see, when i dare to spread the Numbers given in the last update by the company. I will use the lower estimate.

THE NUMBERS : REVENUE for FY = 162 MIL 44/56 Earning SPLIT. EBITDA margins 14.6%

162 x 0.44 x 14.6% = Ebitda of 10.4 mil for 1HY

Next calculation of EPS , assuming NPAT is 60% of Ebitda (from previous years), and we have 160 mil shares on the registry.

Ebitda of 10.4 X 0 .60 : 160 = EPS of 3.9c for 1HY and Maybe a DIV of 2.0c in March

I have looked through EMPIRE ( EPD) HY Report this morning, saw the SP going up on the results and decided to BUY more shares in RXP.

Expand

I reckon you may be shooting a little high with the 2cps interim divi, even with the progressive dividend policy.

Would be very happy to see targets being met and growth going forward plus some upgrade of the dividend.

Hopefully the ‘Works’ is doing the work.

RXP Price at posting: 63.0¢ Sentiment: Buy Disclosure: Held
1 Upvote

0 Great analysis

Reply

Top Stories

NTI

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

WCN

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

BUX

Buxton projects new graphite province discovery at WA Narryer play

BCI

BCI reaches close of funding facility for salt-first part of Mardie project

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

CKA

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

SLS

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

First 22 Last

Add RXP (ASX) to my watchlist